Sara Rummelhoff, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Sara Rummelhoff’s office at (650) 723-4000 to ask if they take your plan before you enroll.
Medicaid work
$660 in 2020
Medicaid paid $660 for 32 billed services this clinician did in 2020, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| 1ST HOSP IP/OBS SF/LOW 40 | 32 | $660 |
| 2020 | 32 | 1 | 18 | $660 |
Drugs they prescribed that Part D paid
$51,747
Pharmacies billed $51,747 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 485) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
434 generic and 51 brand-name prescriptions · $51,747 in drug cost · 30 antibiotic prescriptions to 30 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 30 | $28,238 | $941 |
| Losartan | 61 | $712 | $12 |
| Metoprolol | 53 | $548 | $10 |
| Atorvastatin | 39 | $421 | $11 |
| Rosuvastatin | 41 | $359 | $9 |
See all 10 drugs
| Eliquis | 30 | $28,238 | $941 |
| Losartan | 61 | $712 | $12 |
| Metoprolol | 53 | $548 | $10 |
| Atorvastatin | 39 | $421 | $11 |
| Rosuvastatin | 41 | $359 | $9 |
| Amlodipine Besylate | 43 | $339 | $8 |
| Labetalol | 16 | $167 | $10 |
| Cephalexin | 27 | $108 | $4 |
| Carvedilol | 21 | $83 | $4 |
| Furosemide | 13 | $27 | $2 |
Year by year
| 2024 | 485 | 139 | 0% (0) | 11% | $51,747 |
| 2023 | 196 | 79 | 0% (0) | 14% | $25,725 |
| 2022 | 16 | 14 | None | None | $291 |
| 2020 | 28 | 13 | None | None | $2,674 |
| 2019 | 14 | 12 | 86% (12) | 0% | $155 |
| 2018 | 11 | None | None | 0% | $166 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Colchicine | 16 | $1,041 | $65 |
| Metoprolol | 17 | $308 | $18 |
| Pantoprazole | 15 | $96 | $6 |
| Furosemide | 12 | $58 | $5 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 12 | $140 | $12 |
Money from drug and device companies
$1,017 in 2025
| 2025 | 6 | 9 | None | $1,017 |
| 2022 | 6 | 11 | None | $226 |
| 2021 | 13 | 35 | None | $900 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $216 | 2 payments
|
| Medtronic | Corevalve Evolut R | $202 | 3 payments
|
| Abbott Laboratories | Navitor | $195 | 1 payment
|
| Heartflow | Ffrct | $192 | 1 payment
|
| Biosense Webster | Carto 3 | $147 | 1 payment
|
| Boston Scientific | Watchman Flx | $65 | 1 payment
|
See all 9 published payments
| Biosense Webster | Meals · 2025-12-12 | Carto 3 | $147 |
| Edwards Lifesciences | Meals · 2025-12-05 | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $25 |
| Edwards Lifesciences | Travel · 2025-11-19 | None | $192 |
| Medtronic | Meals · 2025-10-28 | Corevalve Evolut R | $133 |
| Boston Scientific | Meals · 2025-10-26 | Watchman Flx | $65 |
| Abbott Laboratories | Meals · 2025-10-25 | Navitor | $195 |
| Heartflow | Meals · 2025-10-23 | Ffrct | $192 |
| Medtronic | Meals · 2025-10-19 | Corevalve Evolut R | $26 |
| Medtronic | Meals · 2025-09-04 | Corevalve Evolut R | $43 |
See earlier years (2022, 2021)
2022: $226
| GlaxoSmithKline | Nucala | $128 | 6 payments
|
| Lundbeck | Vyepti | $25 | 1 payment
|
| Amgen | Evenity | $22 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $20 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $19 | 1 payment
|
| Medtronic | Powerease Instruments | $12 | 1 payment
|
2021: $900
| AbbVie | Dalvance | $243 | 8 payments
|
| Ucb | Cimzia | $145 | 7 payments
|
| Alexion Pharmaceuticals | Soliris | $141 | 2 payments
|
| Amgen | Evenity | $61 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $61 | 3 payments
|
| GlaxoSmithKline | Nucala | $58 | 3 payments
|
| Lundbeck | Vyepti | $41 | 2 payments
|
| Daiichi Sankyo | Injectafer | $35 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | None | $28 | 2 payments
|
| AMAG Pharmaceuticals | Feraheme | $25 | 1 payment
|
| Janssen Biotech | Stelara | $23 | 1 payment
|
| Genentech USA | Ocrevus | $23 | 1 payment
|
| Novartis Pharmaceuticals | None | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1497277354
- Licence
- CA 95021893
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2017-07-12
- NPI last updated
- 2023-03-28
- NPI record certified
- 2023-03-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 725 Welch Rd, Palo Alto, CA, 94304 · 400 Parnassus Ave Fl 2, San Francisco, CA, 94143
This office lists an electronic records connection.